Form 4: Inspire Medical Systems Director Jerry C. Griffin Executes Stock Option and Sells Shares Under 10b5-1 Plan

Director Jerry C. Griffin exercised stock options and sold shares of Inspire Medical Systems, Inc. under a pre-arranged 10b5-1 trading plan.

Summary

• On March 1, 2024, Jerry C. Griffin, a director of Inspire Medical Systems, Inc., exercised stock options to acquire 1,000 shares of common stock at a price of $16 per share.
• Concurrently, Griffin sold 54 shares at $179.44 and 500 shares at $179.44, totaling 554 shares sold on the same day.
• These transactions were executed under a 10b5-1 trading plan adopted on November 30, 2023.
• Following these transactions, Griffin directly owns 9,798 shares of Inspire Medical Systems, Inc. common stock and holds options for 3,296 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing simply reports transactions under a pre-existing plan, with no indication of positive or negative developments for the company.

Positives

• The transactions were executed under a pre-arranged 10b5-1 trading plan, indicating a planned and transparent approach to stock transactions.

Risks

• Sales of shares by a director could be perceived negatively by the market, although the 10b5-1 plan mitigates this concern.

Future Outlook

The filing does not contain any specific forward-looking statements regarding the company's future performance.

Industry Context

This filing is a routine disclosure of insider transactions and doesn't necessarily reflect broader industry trends. However, monitoring insider activity can provide insights into management's perspective on the company's valuation and future prospects.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the director's sale of shares, but the 10b5-1 plan mitigates concerns about opportunistic selling.

Key Dates